Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Codexis Inc (CDXS)

Codexis Inc (CDXS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 116,518
  • Shares Outstanding, K 90,324
  • Annual Sales, $ 59,350 K
  • Annual Income, $ -65,280 K
  • EBIT $ -60 M
  • EBITDA $ -53 M
  • 60-Month Beta 2.44
  • Price/Sales 2.08
  • Price/Cash Flow N/A
  • Price/Book 3.35

Options Overview Details

View History
  • Implied Volatility 440.68% (-189.33%)
  • Historical Volatility 69.31%
  • IV Percentile 95%
  • IV Rank 68.81%
  • IV High 630.01% on 01/28/26
  • IV Low 23.08% on 09/09/25
  • Expected Move (DTE 22) 0.0000 (0.00%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 11
  • Volume Avg (30-Day) 42
  • Put/Call OI Ratio 0.05
  • Today's Open Interest 2,145
  • Open Int (30-Day) 1,831
  • Expected Range 1.3250 to 1.3250

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate 0.00
  • Number of Estimates 2
  • High Estimate 0.03
  • Low Estimate -0.02
  • Prior Year -0.13
  • Growth Rate Est. (year over year) N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.2500 +6.00%
on 01/29/26
1.8850 -29.71%
on 01/23/26
-0.3150 (-19.21%)
since 12/29/25
3-Month
1.2500 +6.00%
on 01/29/26
2.4799 -46.57%
on 10/30/25
-1.0950 (-45.25%)
since 10/29/25
52-Week
1.2500 +6.00%
on 01/29/26
4.6300 -71.38%
on 01/30/25
-3.1450 (-70.36%)
since 01/29/25

Most Recent Stories

More News
Codexis Expands Reach of the ECO Synthesis® Manufacturing Platform through a Signed Evaluation Agreement with Axolabs for Oligonucleotide Therapeutics

REDWOOD CITY, Calif. , Jan. 7, 2026 /PRNewswire/ -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing and Axolabs, part...

CDXS : 1.3150 (+1.94%)
Codexis Announces Signing of Lease for GMP Manufacturing Facility

REDWOOD CITY, Calif., Nov. 10, 2025 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for the efficient and scalable manufacturing of complex therapeutics, today...

CDXS : 1.3150 (+1.94%)
Codexis: Q3 Earnings Snapshot

Codexis: Q3 Earnings Snapshot

CDXS : 1.3150 (+1.94%)
Codexis Reports Third Quarter 2025 Financial Results

Announces signing of $37.8m Supply Assurance Agreement with Merck Organizational changes streamline company and reduce operational expenses Cash runway extended through 2027 REDWOOD CITY,...

CDXS : 1.3150 (+1.94%)
Codexis and Nitto Denko Avecia Enter Evaluation Agreement to Explore Codexis's ECO Synthesis® Manufacturing Platform for Therapeutic siRNA Manufacturing

REDWOOD CITY, Calif. , Oct. 29, 2025 /PRNewswire/ -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, and Nitto Denko...

CDXS : 1.3150 (+1.94%)
Codexis to Report Third Quarter 2025 Financial Results on November 6

REDWOOD CITY, Calif., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for the efficient and scalable manufacturing of complex therapeutics, today...

CDXS : 1.3150 (+1.94%)
Codexis to Participate in Cantor Global Healthcare Conference

REDWOOD CITY, Calif., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for the efficient and scalable manufacturing of complex therapeutics,...

CDXS : 1.3150 (+1.94%)
Codexis: Q2 Earnings Snapshot

Codexis: Q2 Earnings Snapshot

CDXS : 1.3150 (+1.94%)
Codexis Reports Second Quarter 2025 Financial Results

Announces revenue of $15.3M vs $14.1M analyst consensus estimate Six presentations featured ECO Synthesis® platform at 2025 TIDES USA annual meeting, including three from leading CDMO collaborators...

CDXS : 1.3150 (+1.94%)
Codexis to Report Second Quarter 2025 Financial Results on August 13

REDWOOD CITY, Calif., July 30, 2025 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for the efficient and scalable manufacturing of complex therapeutics, today...

CDXS : 1.3150 (+1.94%)

Business Summary

Codexis is a leading protein engineering company that applies its proprietary CodeEvolver technology to develop proteins for a variety of applications, including as biocatalysts for the commercial manufacture of pharmaceuticals, fine chemicals and industrial enzymes, and enzymes as biotherapeutics and...

See More

Key Turning Points

3rd Resistance Point 1.6200
2nd Resistance Point 1.5500
1st Resistance Point 1.4200
Last Price 1.3150
1st Support Level 1.2200
2nd Support Level 1.1500
3rd Support Level 1.0200

See More

52-Week High 4.6300
Fibonacci 61.8% 3.3388
Fibonacci 50% 2.9400
Fibonacci 38.2% 2.5412
Last Price 1.3150
52-Week Low 1.2500

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar